Sleep duration over 28 years, cognition, gray matter volume, and white matter microstructure: a prospective cohort study.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
12 05 2020
Historique:
received: 18 09 2019
revised: 28 10 2019
pubmed: 7 1 2020
medline: 15 4 2021
entrez: 7 1 2020
Statut: ppublish

Résumé

To examine the association between sleep duration trajectories over 28 years and measures of cognition, gray matter volume, and white matter microstructure. We hypothesize that consistently meeting sleep guidelines that recommend at least 7 hours of sleep per night will be associated with better cognition, greater gray matter volumes, higher fractional anisotropy, and lower radial diffusivity values. We studied 613 participants (age 42.3 ± 5.03 years at baseline) who self-reported sleep duration at five time points between 1985 and 2013, and who had cognitive testing and magnetic resonance imaging administered at a single timepoint between 2012 and 2016. We applied latent class growth analysis to estimate membership into trajectory groups based on self-reported sleep duration over time. Analysis of gray matter volumes was carried out using FSL Voxel-Based-Morphometry and white matter microstructure using Tract Based Spatial Statistics. We assessed group differences in cognitive and MRI outcomes using nonparametric permutation testing. Latent class growth analysis identified four trajectory groups, with an average sleep duration of 5.4 ± 0.2 hours (5%, N = 29), 6.2 ± 0.3 hours (37%, N = 228), 7.0 ± 0.2 hours (45%, N = 278), and 7.9 ± 0.3 hours (13%, N = 78). No differences in cognition, gray matter, and white matter measures were detected between groups. Our null findings suggest that current sleep guidelines that recommend at least 7 hours of sleep per night may not be supported in relation to an association between sleep patterns and cognitive function or brain structure.

Identifiants

pubmed: 31904084
pii: 5697049
doi: 10.1093/sleep/zsz290
pmc: PMC7215267
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/K013351/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : K99 AG056598
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034454
Pays : United States
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/2/30098
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/11/63/29011
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001354
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL036310
Pays : United States
Organisme : Medical Research Council
ID : K013351
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Sleep Research Society 2020. Published by Oxford University Press [on behalf of the Sleep Research Society].

Références

Hum Brain Mapp. 2017 Nov;38(11):5465-5473
pubmed: 28745016
Am J Epidemiol. 2016 Mar 15;183(6):561-73
pubmed: 26940117
Health Rep. 2013 Nov;24(11):14-20
pubmed: 24259200
Sleep Med Rev. 2018 Jun;39:25-36
pubmed: 28890167
Am J Epidemiol. 2019 Jun 1;188(6):1066-1075
pubmed: 30759177
Sleep. 2016 May 01;39(5):1121-8
pubmed: 26951390
PLoS One. 2015 Nov 16;10(11):e0142533
pubmed: 26569414
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
Sleep. 2015 Aug 01;38(8):1161-83
pubmed: 26194576
Int J Geriatr Psychiatry. 2010 Jan;25(1):100-9
pubmed: 19548221
Sleep. 2004 May 1;27(3):440-4
pubmed: 15164896
Psychopharmacology (Berl). 1993;110(4):395-401
pubmed: 7870908
BMC Psychiatry. 2014 May 30;14:159
pubmed: 24885374
Int J Epidemiol. 2005 Apr;34(2):251-6
pubmed: 15576467
Psychol Bull. 1990 Mar;107(2):238-46
pubmed: 2320703
Curr Biol. 2019 Mar 18;29(6):957-967.e4
pubmed: 30827911
J Clin Sleep Med. 2007 Oct 15;3(6):622-30
pubmed: 17993045
J Pediatr Psychol. 2014 Mar;39(2):188-203
pubmed: 24277770
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
BMC Public Health. 2018 Mar 7;18(1):332
pubmed: 29514633
Sleep. 2014 Jul 01;37(7):1171-8
pubmed: 25061245
Sleep. 2016 Sep 01;39(9):1743-7
pubmed: 27397561
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
J Am Geriatr Soc. 2014 Jun;62(6):1073-81
pubmed: 24786726
J Sleep Res. 2019 Feb;28(1):e12712
pubmed: 29790200
J Sleep Res. 2014 Oct;23(5):524-30
pubmed: 25040435
Epidemiology. 2008 Nov;19(6):838-45
pubmed: 18854708
Sleep Med. 2016 Jan;17:87-98
pubmed: 26847980
Sleep. 2011 May 01;34(5):565-73
pubmed: 21532949
Sleep Health. 2015 Mar;1(1):40-43
pubmed: 29073412
Brain. 2007 Sep;130(Pt 9):2375-86
pubmed: 17698497
Hum Brain Mapp. 2016 Apr;37(4):1486-511
pubmed: 26848101
Child Dev. 2011 Sep-Oct;82(5):1357-71
pubmed: 21824131
Sleep Med. 2017 Apr;32:246-256
pubmed: 27743803

Auteurs

Jennifer Zitser (J)

Department of Neurology, Global Brain Health Institute, Memory and Aging Center, University of California, San Francisco, CA.
Department of Neurology, Movement Disorders Unit, Tel Aviv Sourazky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Melis Anatürk (M)

Department of Psychiatry, University of Oxford, Oxford, UK.

Enikő Zsoldos (E)

Department of Psychiatry, University of Oxford, Oxford, UK.
Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK.
FMRIB, Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.

Abda Mahmood (A)

Department of Psychiatry, University of Oxford, Oxford, UK.

Nicola Filippini (N)

Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK.

Sana Suri (S)

Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK.

Yue Leng (Y)

Department of Neurology, Global Brain Health Institute, Memory and Aging Center, University of California, San Francisco, CA.
Department of Psychiatry, University of California, San Francisco, CA.

Kristine Yaffe (K)

Department of Psychiatry, Neurology and Epidemiology, University of California, San Francisco, CA.

Archana Singh-Manoux (A)

Université de Paris, Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.
Department of Epidemiology and Public Health, University College London, London, UK.

Mika Kivimaki (M)

Department of Epidemiology and Public Health, University College London, London, UK.

Klaus Ebmeier (K)

Department of Psychiatry, University of Oxford, Oxford, UK.

Claire Sexton (C)

Department of Neurology, Global Brain Health Institute, Memory and Aging Center, University of California, San Francisco, CA.
Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH